🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 129 of 173

  1. US 7674787

    Conformationally constrained Smac mimetics and the uses thereof

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7674249

    Gels with predetermined conductivity used in electroporation of tissue

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7670855

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7670599

    YKL-40 as a marker and prognostic indicator for cancers

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7670600

    Molecules with extended half-lives, compositions and uses thereof

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7670767

    Genetic alterations associated with cancer

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7666886

    Compounds and methods for the diagnosis and treatment of amyloid associated diseases

    Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7668662

    Patient-specific dosimetry

    Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7662780

    Administering hypocretin to obese individuals

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7662910

    Inhibitors for the soluble epoxide hydrolase

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7662923

    Modified vitamin K-dependent polypeptides

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7659071

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7659371

    Patched polypeptides and uses related thereto

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7659306

    Method of increasing gastric emptying

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7659118

    Multipotent adult stem cells

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7658923

    Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7655252

    Antimicrobial nanoemulsion compositions and methods

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7655241

    Methods and compositions for vaccination against or involving enterobacteriaceae bacteria

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7655695

    Illudin analogs useful as anticancer agents

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7655472

    Treatment of disease by inducing cell apoptosis

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7651707

    Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7651845

    Method and apparatus for glucose control and insulin dosing for diabetics

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7652077

    Graft prosthesis, materials and methods

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7652001

    Pharmacologically active agents containing esterified phosphonates and methods for use thereof

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7651847

    Methods of oligosaccharide profiling for the detection of cancer

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7648826

    Detecting CYP24 expression level as a marker for predisposition to cancer

    Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7649088

    Atlastin

    Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7645732

    Treating hepatitis C virus infection

    Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7645885

    Non-steroidal antiandrogens

    Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7642234

    Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

    Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7641902

    Compositions and methods for detecting cancer and for inhibiting metastasis

    Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7642280

    Inhibitors of acyl glucosaminyl inositol amidase and methods of use

    Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7638145

    Cultivated agarwood

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7638135

    Collagen-binding proteins from enterococcal bacteria

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7638300

    In vivo incorporation of unnatural amino acids

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7638624

    Compositions and methods relating to novel benzodiazepine compounds and derivatives

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7638284

    Immunoglobulin A inducing protein and uses therefor

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7638494

    G-type peptides to ameliorate atherosclerosis

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7638544

    Dimeric small molecule potentiators of apoptosis

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7638501

    Method of treatment of mitochondrial disorders

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7638507

    Compositions for treatment of inflammatory diseases

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7638543

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7638678

    Animal model for perimenopause and menopause and methods of inducing ovarian failure

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7638269

    Viral capsid assembly intermediates and methods of production

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7638640

    Purifications of pomegranate ellagitannins and their uses thereof

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7638282

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7635483

    Streptococcal C5a peptidase vaccine

    Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7635712

    Salinosporamides and methods for use thereof

    Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.